INTELLECTUAL PROPERTYAt the heart of Neuralstem’s therapeutic cell development programs is the is ability to isolate and grow human neural stem cells from diverse regions of the developing human brain and spinal cord.
This technology is supported by our portfolio of issued and pending patents. The Company has a very pro active plan for obtaining and protecting its stem cell Intellectual Property, not just in the United States, but world wide. In addition to its stem cell intellectual property, the Company has been active in licensing important intellectual property rights for newly developed devices and equipment that will be required to optimize delivery of its stem cell therapeutics through surgical transplantation into the brain and spinal cord.
Patents Issued
View Pending Patents
Patent # | Country | Filing
Date | Issue
Date | Expiration
Date | Title | 5,753,506 | United States | 9/25/1996 | 5/19/1998 | 9/25/2016 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 6,040,180 | United States | 5/7/1997 | 3/21/2000 | 5/7/2017 | In Vitro Generation of Differentiated Neurons from Cultures of Mammalian Multi-Potential CNS Stem Cells | 6,284,539 | United States | 10/9/1998 | 9/4/2001 | 10/9/2018 | Method for Generating Dopaminergic Cells Derived from Neural Precursors | 755849 | Australia | 9/20/1999 | 4/3/2003 | 9/20/2019 | Stable Neural Stem Cell Lines | 0915968 | France | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 69737949.3 | Germany | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 0915968 | Ireland | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 0915968 | Spain | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 0915968 | Sweden | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 0915968 | Switzerland | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 0915968 | United Kingdom | 5/7/1997 | 7/25/2007 | 5/7/2017 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 7,544,511 | United States | 1/14/2002 | 6/9/2009 | 4/13/2017 | Stable Neural Stem Cell Lines | 7,560,553 | United States | 3/17/2008 | 7/14/2009 | 8/9/2024 | Use of Fused Nicotinamides to Promote Neurogenesis | 132324 | Singapore | 11/17/2005 | 11/30/2009 | 11/17/2025 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders |
Patents Pending
View Issued Patents
Application # | Country | Filing Date | Title | 2257068 | Canada | 5/7/1997 | Isolation Propagation and Directed Differentiation of Stem Cells from Embryonic and Adult Central Nervous System of Mammals | 2343571 | Canada | 9/20/1999 | Stable Neural Stem Cell Lines | 2000-574224 | Japan | 9/20/1999 | Stable Neural Stem Cell Lines | 99948396.9 | Euro. Patent Co | 9/20/1999 | Stable Neural Stem Cell Lines | 037903564 | Euro. Patent Co | 12/5/2003 | Method for Discovering Neurogenic Agents | 200580039450.0 | China | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 05851748.3 | Euro. Patent Co | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 2613/CHENP/2007 | India | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 183092 | Israel | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 2007-543219 | Japan | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 20073078 | Norway | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 1-2007-501016 | Philippines | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 2007122507 | Russia, Fed. Of | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 10-2007-7012097 | South Korea | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 1-2007-01216 | Vietnam | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurodegenerative Conditions | 11/281,640 | United States | 11/17/2005 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 11/852,922 | United States | 9/10/2007 | Method for Discovering Neurogenic Agents | 08106303.1 | Hong Kong | 6/5/2008 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders | 12/404,841 | United States | 3/16/2009 | Methods of Treating Ischemic Spasticity | 12/424,238 | United States | 4/15/2009 | Stable Neural Stem Cell Lines | 12/500,073 | United States | 7/9/2009 | Use of Fused Nicotinamides to Promote Neurogenesis | 12/710,097 | United States | 2/22/2010 | Transplantation of Human Neural Cells for Treatment of Neurological Disorders |
| 